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Abstract
Diabetes is one of the leading chronic diseases affecting Australians and its prevalence
continues to rise. Diabetes is therefore becoming a serious challenge for both the
quality of healthcare and expenditure in the Australian healthcare system. The goal of
this study is to investigate the development and application of DiaMonD – a diabetes
monitoring device. Powered by pervasive technology software developed by INET,
DiaMonD is a wireless enabled mobile phone that can facilitate superior diabetes selfmanagement. The development and application of DiaMonD using the Adaptive
Mapping to Realisation methodology (AMR) methodology is examined in addition to an
appraisal of key adoption facilitators and barriers in the Australian setting.
Key words: healthcare, diabetes, self-management, wireless, pervasive technologies,
Australia

1

Introduction

Diabetes is one of the leading chronic diseases affecting Australians and its prevalence
continues to rise. The total number of diabetes patients worldwide is estimated to rise to
366 million in 2030 from 171 million in 2000 (Wild, Roglic, Green, Sicree, & King,
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2004). With increasingly growing prevalence which includes an estimated 275
Australians developing diabetes daily (DiabetesAustralia, 2008), Australia is expected
to be a significant contributor to this projected trend. In fact, an estimated 700,000
Australians representing approximately 3.6% of the population were diagnosed with
diabetes in 2004-05 and between 1989-90 and 2004-05 the proportion of people
diagnosed with this disease more than doubled from 1.3% to 3.3%. Additionally,
between 2000-01 and 2004-05, diabetes hospitalisations increased by 35% from 1,932
to 2,608 hospitalisations per 100,000 people (AIHW, 2008). Recent statistics also show
that for every person diagnosed with diabetes, it is estimated that there is another who
has yet to be diagnosed which doubles the number of diabetes sufferers
(DiabetesAustralia, 2008). Diabetes is, thus, one of the fastest growing chronic diseases
in Australia (AIHW, 2008; Catanzariti, Faulks, & Waters, 2007; Chittleborough, Grant,
Phillips, & Taylor, 2007).
Diabetes can have a major impact on the quality of life of its patients and its long-term
effects can evolve into serious complications. For instance, people with diabetes are at
greater risk of developing cardiovascular, eye or kidney diseases, lower limb
amputation and even reduced life expectancy than people without diabetes (AIHW,
2008; Rasmussen, Wellard, & Nankervis, 2001; Tong & Stevenson, 2007). These
complications can lead to death, and currently, diabetes ranks as the sixth leading cause
of death in Australia (DiabetesAustralia, 2008)
Evidence also shows that diabetes and its complications incur significant costs for the
health system in Australia including costs incurred by carers, government, and the entire
health system (DiabCostAustralia, 2002). For instance, in 2004-05 direct healthcare
expenditure on diabetes was A$907 million which constituted approximately 2% of the
allocatable recurrent health expenditure in that year (AIHW, 2008). Further costs
include societal costs that represent productivity losses for both patients and their carers
(DiabCostAustralia, 2002).
Diabetes can, therefore, have considerable social, human, and economic impacts and
tackling these requires solutions that substantially enhance the existing fragmented and
uncoordinated capacity for effective prevention, early detection and management
(VictorianGovernment, 2007). Hence, a treatment imperative is to provide patients with
appropriate levels of monitoring to ensure containment of the disease and prevention of
further complications. Given the exponential growth predicted for patients suffering
from this disease coupled with the geographic spread across Australia (AIHW, 2008), a
pervasive technology solution would offer the necessary monitoring that is both cost
effective, convenient to both patients and clinicians and least disruptive to patient life
style.
Recognizing the need to have a solution that can enable the ubiquitous monitoring of
diabetes patients while also continuously educating them, the goal of this paper is to
investigate the development and application of DiaMonD – a diabetes monitoring
device. Powered by pervasive technology software developed by INET, DiaMonD is a
wireless enabled mobile phone that can facilitate superior diabetes self-management in
the Australian setting. The realization of this goal can contribute by establishing a
benchmark for theoretical and empirical testing. To achieve this goal, first, we provide a
general background on the Australian health scene and critically review existing
research. An elaboration of the proposed pervasive mobile technology solution and of
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the anticipated barriers and facilitators the Australian setting is then provided. The
academic rigor is achieved through various key components starting with the use of the
chronic care model to identify support from findings the benefits and need of patient
self-empowerment, to date not well recognised with the design of various technology
solutions for all areas of chronic diseases, the research methodology of the refocused
systems development model which incorporates the unique delivery framework from
which a suitable business model is developed to support a sustained solution and the
unique development and application of the AMR methodology. Future trends are
subsequently discussed before the paper is concluded.

2

Current Australian Health Scene

Both healthcare professionals and diabetes patients require quality information if
disease conditions are to be effectively managed. Extant research shows that there are
several deficiencies in the information provided by the existing system for monitoring
diabetes in Australia (Dixon & Webbie, 2006; Sprivulis et al., 2007; Swerissen &
Taylor, 2008). First, data collected in hospitals are episode-based rather than patientbased which makes it difficult to determine statistics concerning individual admissions,
re-admissions, and treatment patterns. Second, there is lack of data on incidence and
prevalence by diabetes type that can help reliably assess the magnitude of the problem.
Third, the accuracy of recording data in administrative data sets, such as hospital
morbidity, mortality and general practice data is uncertain. Finally, clinical management
information is derived from uncoordinated and fragmented data collections that are not
representative of the entire population of diabetes patients making comparison, analysis
and trend identification difficult.
These deficiencies are the result of the current health system set up. Based on fee-forservice episodic doctor-patient consultation, the current Australian healthcare system
can handle short-term illnesses involving a limited range of interventions including their
diagnosis and treatment (Hunt, 2007). However, this system is comprised of a mixture
of fragmented private and public healthcare subsystems that provide both healthcare
funding and delivery. Largely uncoordinated, these subsystems are deemed to be
unsuitable for the treatment of long-term chronic diseases including diabetes (Dixon &
Webbie, 2006; Sprivulis et al., 2007). In particular, diabetes requires teams of various
health professionals and long-term support to help sufferers make effective healthy
lifestyle changes and constantly maintain them (Hunt, 2007).

3

Current Diabetes Self-management Research

As there is no cure for diabetes, non-medical approaches are used jointly with medical
approaches so that patients can have a life which is as normal as possible. However,
non-medical approaches can be challenging as they require effective lifestyle
management and meticulous attention and monitoring by both patients and healthcare
professionals (Britt et al., 2007). Particularly, to be successful, patients to be both
informed and active in their treatment regimen (AIHW, 2007, 2008). This can be
achieved by effective self-management which is a non-medical approach and which
constitutes the focus of this paper.
Self-management is important as it empowers diabetes patients while acknowledging
their central role and responsibility for managing their healthcare (ICIC, 2008). Extant
research indicates that active participation of diabetes patients in self-management is a
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key strategy for managing their condition and reaching improved treatment outcomes
(Colagiuri, Colagiuri, & Ward, 1998; Poulton, 1999; Rasmussen et al., 2001; Wellard,
Rennie, & King, 2008). However, self-management is constantly time-consuming and
requires significant self-discipline (Russell, Churl Suh, & Safford, 2005) and support
strategies including assessment, goal-setting, action-planning, problem-solving and
follow-up (ICIC, 2008). Moreover, because effective self-management may require
patient interaction with various healthcare professionals, including general practitioners,
diabetes educators, dieticians, and community nurses (Knuiman, Welborn, &
Bartholomew, 1996), difficulties can arise when diabetes patients encounter problems
ranging from making appointments to needing to travel to many locations (Van Eyk &
Baum, 2002; Wellard et al., 2008; Zigbor & Songer, 2001). Given both the importance
and complexity of applying self-management effectively for both prevention and early
detection of diabetes, there are increasing calls for further research to facilitate selfmanagement (Wellard et al., 2008).
A model proposed by Wagner (2008) requires productive interactions between informed
and activated patients and prepared and proactive healthcare professionals (ICIC, 2008).
One of the most important ways to achieve or at least facilitate this, entails the
development of suitable information systems for building patient capacity to undertake
self-management successfully (Joshy & Simmons, 2006). These information systems
should provide the possibility for ubiquitous monitoring of an individual’s diabetes
conditions, thereby, supporting the effective self-management of the disease. While
being useful and easy to use so that patients can readily accept and interact with them in
a meaningful manner, these systems also need to be robust and cost-effective to
implement and provide auditing and benchmarking tools that are critical for the
surveillance of patients (Joshy & Simmons, 2006). Additionally, these systems should
provide patient summary profiles in a cost effective manner that can empower diabetes
clinicians with the ability to manage diabetes issues on an ongoing basis to improve
patient care (Joshy & Simmons, 2006).
Current methods used in Australia for achieving patient self management include
various types of training and education and support options including peer-led, generic
and tailored chronic disease self-management planning, training and support, telephone
coaching etc. (Francis, Feyer, & Smith, 2007; Harvey et al., 2008). Although these were
found to be effective to various extents, they are also resource-intensive and their longterm sustainability is questionable (Francis et al., 2007). Additionally, current research
shows that quality improvement factors including timeliness, confidentiality, continuity,
dignity, communication, access, education, cost, amenities and autonomy, still remain
relatively elusive in the ambit of chronic disease services including diabetes (Tabrizi,
Wilson, Coyne, & O'Rourke, 2008).
Although current research has provided solutions for supporting self-management
(Chau & Turner, 2006; Rudi & Celler, 2006) these have not always been effective due
to the reality that “patients did not learn how to do it [apply the solutions] or they did
not understand the rules which were explained to them, or they are not sure enough of
their knowledge, uncertainty entailing indecision” (Reach, Zerrouki, Leclercq, &
d'Ivernois, 2005). Nevertheless, research shows that computer-assisted telemedicine can
help people with diabetes improve both their self-management (Balas et al., 2004) and
their relationship with healthcare professionals (Bodenheimer, Lorig, Holman, &
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Grumbach, 2002; Downer, Meara, Da Costa, & Sethuraman, 2006). Therefore, in this
paper, we investigate the development and application of DiaMonD as a pervasive
mobile technology solution to facilitate superior diabetes self-management.

4

The Development of a Pervasive Mobile Technology
Solution

We propose DiaMonD – diabetes monitoring device – as a solution which incorporates
software that facilitates the ubiquitous monitoring of an individual’s diabetes, thereby,
contributing to diabetes self-management. The solution is grounded in trying to support
key components of a chronic disease care model (Table 1).
The journey began by realizing that the traditional System Development Lifecycle
(SDLC) was fundamentally flawed for healthcare initiatives. This was due to several
reasons including the length of time it would take to realize the final application and the
structures and inflexible stages that had to be traversed. Thus, INET developed a
refocused SDLC model (figure 1a) and delivery framework (figure 1b). It was, thus,
possible to keep the strengths of SDLC and yet move from start to finish in a much
more compressed time frame (Table 2).
Table 1 Components of Chronic Care Model (Rachlis, 2006)
Component

Description

Organisation of Health
System

Self-management support

Decision Support

Delivery System design

Clinical

Information

•

Leadership in chronic disease management (CDM)

•

Goals for CDM

•

Improvement strategy for CDM

•

Incentives and regulations for CDM

•

Benefits

•

Assessment and documentation of needs and activities

•

Addressing concerns of patients

•

Effective behaviour change interventions

•

Evidence-based guidelines

•

Involvement of specialists in improving primary care

•

Providing education for CDM

•

Informing patients about guidelines

•

Practice team functioning

•

Practice team leadership

•

Appointment system

•

Follow-up

•

Planned visits for CDM

•

Continuity of Care

•

Registry
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Systems

Community

•

Reminders to providers

•

Feedback

•

Information about relevant subgroups of patients needing services

•

Patient treatment plans

•

Linkages for patients to resources

•

Partnerships with community organizations

•

Policy and plan development

Refocus 1 to 5 year systems development
life cycle into small manageable pieces
Measurable
Benefits

Many
eBusiness
Projects

concurrent
Acceleration

Traditional 1 to 5 Year
Systems Development Life
Cycle Project

1 to 5 Years

Figure1a: Refocused SDLC Model
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Scope:
•Physician-Lead
•Commercial Sponsors
•Researchers
•Healthcare Delivery Team

Localize:
Evaluate:
•Final Report:
Project
•Description
and pre/post
results to be
used in
publications

INET Mobile Ehealth Project
Actualize
Physician-led
Innovations In
Chronic Disease
Management

Field:

•Develop current
and new process
•Gather and
document
requirements
•Develop/Customize
Applications
•Set-up system &
sign-off

•Prepare and achieve
ethics review approval
•Enroll patients.
•Acquire application licensing
fees
•Set-up the support
•On-ongoing support

Figure 1b: Components of the Delivery Framework
The research goal is to use a standardized mobile Internet (wireless) environment to
improve patient outcomes with immediate access to patient data and provide the best
available clinical evidence at the point of care. To achieve this, INET International
Inc.’s research (S. e. a. Goldberg, 2002a, 2002b, 2002c, 2002d, 2002e; Wickramasinghe
& Goldberg, 2003, 2004) starts with a 30-day e-business acceleration project in
collaboration with many key actors in hospitals, such as clinicians, medical units,
administration, and I.T. departments. Together, they follow a rigorous procedure that
refocuses the traditional 1-5-year SDLC into concurrent 30-day projects to accelerate
healthcare delivery improvements. At completion, an e-business acceleration project
delivers a scope document to develop a handheld technology application (HTA) proofof-concept specific to the unique needs of a particular environment. The proof-ofconcept is a virtual lab case scenario which operates within a mobile Internet (wireless)
environment by working with hospitals and technology vendors. The final step is the
collection of additional data with clinical HTA trials consisting of two-week hospital
evaluations.
With the refocused SDLC model it was then possible to design a robust and rigorous
web-based business model, the INET web-based business model (figure 2). This
business model provides the necessary components to enable the delivery framework to
be positioned in the best possible manner so it can indeed facilitate enacting the key
components of the chronic disease model successfully (table 1). The model is positioned
to suit the complex nature of healthcare environments by iteratively, systematically, and
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rigorously incorporating lessons learnt data to healthcare processes for ensuring superior
healthcare delivery. This manner does not only maximize the value of past data and
organisational learning but it also makes processes amendable as complex needs and
requirements evolve.
SDLC
(waterfall)
I.T. Role &
Responsibility

INET Mobile e-Health Project
Scope

Localize

Field

Evaluate

Project
Management

Data Analysis

Technical Support

Account
Manager

Business
Analysis

Technical Tools Expert
Programmer
Data Administrator
Network Architect
Database Administrator
Network Administrator

Investigation

Problem
Definition
Feasibility Study
– can objectives
be met at a
reasonable cost.

Document
Solution, Data
analysis
of
outcomes,
benefits
and
Next Steps

Project
Definition
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SDLC
(waterfall)
Analysis
(Logical Design)

INET Mobile e-Health Project
Scope

Localize

Field

Evaluate

Define what the IS must
do to fix the problem
Less temptation to follow
existing practices which
may not be best
Define
the
user’s
requirements
and
priorities Analyze existing
system
Develop logical design
for the new system

Design (Physical
Design)

Implementation

Maintenance

Define how the
system will work

new

Detail
budget

and

Schedule

Produce a physical design
showing system inputs,
outputs, user interfaces.
Research
technology
Product Acquisitions
Test
programs,
subsystems and systems
acquire
or
develop
software
Code programs
Software
developer
manual
System operators manual
Purchase
and
Install
hardware and software
package
Fix
Problem/Solution
Determination

User’s Manual
People Changeover
Tasks
Data Conversion.
Technical
Changeover Tasks

Fix
Database,
Network and 3rd
Party Products
Fix security and
access problems
Fix learning curve
time disruptions
Fix
collaboration
problems

Table 2: INET Practice Framework – Compressing the SDLC
It is important to note that in this business model the three key areas of risk, namely,
people, processes and technology, are minimised through the use of pervasive
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technology which we believe is a unique benefit of the INET solution. Specifically,
since the proposed solution is an application that is compatible with any mobile phone
or wireless device (e.g. a PDA) data transfers occur between patients and providers on a
well vetted model. Therefore, the learning curve for patients may be minimal as they are
likely to be in possession of mobile devices.

Figure 2: INET web-based model
Successful web-based projects in healthcare require the consideration of many
components. Figure 2 provides an integrative model for all key success factors that we
have identified through our research (S. e. a. Goldberg, 2002a, 2002b, 2002c, 2002d,
2002e; Wickramasinghe & Goldberg, 2004; Wickramasinghe & Misra, 2004;
Wickramasinghe, Schaffer, & Geisler, 2005). What makes this model unique and most
beneficial is its focus on enabling and supporting all areas necessary for the
actualization of ICT initiatives in healthcare. By design, the model identifies the inputs
necessary to bring an innovative chronic disease management solution to market. These
solutions are developed and implemented through a physician-led mobile e-health
project. This project is the heart of the model that bridges the needs and requirements of
many different players into a final (output) deliverable, a “Wireless Healthcare
Program”. To accomplish this, the model is continually updated to identify, select and
prioritize the ICT project inputs that will:
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Accelerate healthcare system enhancements and achieve rapid healthcare benefits.
The model identifies key healthcare system inputs with the four Ps, namely, 1)
People that deliver healthcare, 2) Process to define the current healthcare delivery
tasks, 3) Platform used in the healthcare technology infrastructure, and 4)
Protection of patient data.



Close the timing gaps between information research studies and their application in
healthcare operational settings.



Shorten the time cycle to fund an ICT project and receive an adequate return on the
investment.

Together the components of the model will help in actualizing physician-led solution for
the management of chronic diseases in general and of diabetes in particular. The
delivery framework activities (Figure 1a and 2) are ongoing and represent a continuous
improvement cyclical approach towards a given wireless healthcare program. These
activities however require the relevant and complete inputs from the healthcare system
if they are to be carried out successfully. With the refocused SDLC in constructing
mobile e-health solutions, both the healthcare inputs (i.e. the four Ps) and the delivery
framework may require funding from various sources in return for healthcare
improvements and the building up of intelligence in terms of relevant research findings.
To successfully implement the business model described above it was, however,
necessary to have an appropriate methodology. Based on this need the adaptive
mapping to realization methodology (AMR) was developed (figure 3). The idea of the
methodology was to apply a systematic rigorous set of predetermined protocols to each
business case and then map the post-prior results back to the model. In this way, it was
possible to compare and contrast both a priori and post priori findings. From such a
comparison a diagnosis of the current state was made and then prescriptions were
derived for the next business case. Hence, each pilot study incorporated the lessons
learnt from the previous one and the model was adapted in real time.
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t
ho
s
Sn alysi
An
s
ap

Current State
Research
Findings
Medical
Infornatics

Business
Management

Diagnostic
Evaluation

Information &
Comm.. Tech

Patient

Community/Home Care

People

Scope
Primary Care

INET Delivery Fram ew ork
For Healthcare

Future
State

E-Health

Acute Care

INET Mobile
E-Health
Project
Actualize
Physician-led
Innovations In
Chronic
Disease
Management

Medical Compliance

Process

Administration

Information Technology

Privacy

Protection

Security

Reliability
Wireless Devices

Transcoding

Platform

3- Tier App Architecture

Localize

Field

Create,
Implement
and/or
Enhance a
Wireless
Healthcare
Program

Evaluate

Back-end Connection
Pharmaceutical
& Device Firms

Consumers

Government or
3rd Party
Insurer

Employers

Funding Criteria

Prescriptive Evaluation

Time

Figure 3: AMR Methodology
By applying the tools and techniques of today’s knowledge economy as presented in the
intelligence continuum (IC) it is possible to make the AMR methodology into a very
powerful knowledge-based systems development model (figure 4). The IC was
developed by Wickramasinghe and Schaffer (2006) to enable the application of tools
and technologies of the knowledge economy to be applied to healthcare processes in a
systematic and rigorous fashion and thereby ensure superior healthcare delivery. The
collection of key tools, techniques and processes that make up the IC include but are not
limited to data mining, business intelligence/analytics and knowledge management
(Wickramasinghe & Schaffer, 2006).
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Web-based
Actualize
Physician-led
Innovations In
Chronic Disease
Management

Web-based
Actualize
Physician-led
Innovations In
Chronic Disease
Management

data
1

n

descriptive

?
prescriptive

?
Knowledge Management

Business Intelligence/Analytics

Data Mining

Intelligence Continuum

Figure 4: Knowledge-based Systems Development Model
Taken together, they represent a very powerful system for refining the raw data stored
in data marts and/or data warehouses and thereby maximizing the value and utility of
these data assets for any organization. To maximize the value of the data generated
through specific healthcare processes and then use this to improve processes, IC
techniques and tools must be applied in a systematic manner. Once applied, the results
become part of the data set that are subsequently reintroduced into the system and
combined with other inputs of people, processes, and technology to develop an
improvement continuum. Thus, the IC includes the generation of data, the analysis of
these data to provide a “diagnosis”, and their reintroduction into the cycle as a
“prescriptive” solution. In this way, the IC is well suited to the dynamic and complex
nature of healthcare environments and ensures that the future state is always built upon
the extant knowledge-base of the preceding state. Through the incorporation of the IC
with the AMR methodology we then have a knowledge-based systems development
model that can be applied to any setting, not necessarily to chronic disease management.
The power of this model is that it brings best practices and the best available germane
knowledge to each iteration and is both flexible and robust.
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INET Wireless Diabetes Program
Diabetes Care Centre, Credit Valley Hospital
Prevent Diabetes Related
Complications with Better
Control of Glycemic Levels,
Measured by HA1C

People
w/Diabetes
Action
Request
i.e. ”Keep
up the
good work”

Nurse

Enter
Sugar
Level

Diabetes Management System
(Bayer WinGlucofacts & INET Sync)

Receive
Sugar
Levels

Send
Action
Request

GlycemiCare
Server

Patient Privacy: No identifiable
information is transmitted.

Figure 5: ICT Support for Diabetes
Figure 5 describes succinctly the INET solution where patients in the program submit
glucose readings through their cell phones. The patients’ primary care physician
subsequently reviews the results and makes recommendations, which are transmitted
back to the patients’ cell phones for review. This is an alternative method of
communication between the patient and primary care physician to support the control of
patient’s diabetes. The patient creates a bookmark in their cell phone, and then using a
unique patient ID, they gain access to an application to quickly enter glucose readings
and access messages. The physician is given an internet link, and using their unique
physician ID, he or she can quickly access a list of patients, trends and a simple way to
send messages.
Thus, DiaMonD represents a pervasive ICT enabled solution which while not
exorbitantly expensive it facilitates the superior monitoring of diabetes (figure 5). The
proposed solution enables patient empowerment by way of enhancing self-management.
This is a desirable objective because it allows patients to become equal partners with
their clinicians in the management of their own healthcare (Opie, 1998; Radin, 2006) by
enhancing the traditional clinical-patient interactions (Mirza, Norris, & Stockdale,
2008). However, because most work has focused on specific applications and proof-ofconcept studies, this paper would be incomplete without considering the critical success
factors, including facilitators and barriers, that are expected to affect the ubiquitous
adoption of the proposed solution in the Australian setting (Gururajan & Murugesan,
2005; Mirza et al., 2008).

5

Anticipated Barriers and Facilitators in Australia

In order to move smoothly from idea to realisation, we identify and discuss seven
factors that may impede or facilitate the success of DiaMonD in the Australian setting.
First, DiaMonD has the potential to reduce face-to-face interaction between patients and
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their clinicians. While this may be favourable for some patients, it may impact on the
social needs of others for human interaction. This may lead to resistance or even
rejection for adopting DiaMonD at both conscious and subconscious levels (Vanjara,
2006). However, we argue that DiaMonD incorporates mobile phones which are
perceived to confer a social status amongst some segments of society which may well
become an adoption facilitator. Furthermore, usage of mobile phones may also help
eliminate the social stigma that can occur with alternative obvious devices that are used
for monitoring chronic diseases (Mirza et al., 2008).
Second, mobile phones are location-independent which makes healthcare monitoring
both flexible and ubiquitous, that is, not confined to specific settings, such as hospitals
(Istepanian & Lacal, 2003). While also generating potentially significant cost savings
(e.g. by reducing false positive or non serious hospitalisations) for managing the care of
non-critical diabetes sufferers DiaMonD will also improve their quality of life
(Istepanian, Jovanov, & Zhang, 2004; Mirza et al., 2008; Norris, 2002). This may, thus,
facilitate DiaMonD adoption.
Third, the ageing population in Australia combined with the fragmented nature of the
Australian healthcare system that is designed to treat episodic conditions, and the
generally poor awareness of life style implications will increase the pressure on this
system for better chronic disease treatment standards over longer periods (ABS, 2003;
Rowland, 2003). The pervasive nature of DiaMonD combined with its ability to offer
targeted and tailored health messages can contribute to ease that pressure, and
consequently, become a facilitator for its adoption in Australia (Neville, Greene,
McLeod, & Tracy, 2002).
Fourth, there is evidence suggesting that to date, some sectors of the healthcare system
in Australia have not been convinced of the benefits of ICT in general and pervasive
mobile solutions in particular (Yu, Li, & Gagnon, 2008). At least partially, this is due
clinicians’ preference and bias towards traditional face-to-face forms of interactions
with their patients (Skulimowski, 2006). Furthermore, in a recent study, Australian
nurses and clinicians considered that the vast majority of employers did not encourage
ICT training, and for those for whom training was available, heavy workloads were
considered to be major barriers for training uptake (Eley, Fallon, Soar, Buikstra, &
Hegney, 2008). Taken together, these factors are expected to become barriers for the
adoption of DiaMonD. Organisational changes, including establishment or awareness
and training are, thus, required for extended adoption and diffusion (Mirza et al., 2008).
Fifth, DiaMonD is expected to be highly cost-effective for people with diabetes. For
example, costs to patients are estimated to be confined to data transfer charges which
include the systematic texting (e.g. by SMS) of glycemic levels (measured by HA1C
readings). With increasing competition amongst Australian operators, data transfer
charges are expected to decrease in the future (Troshani & Rao, 2007a). Another
possible cost to patients may include mobile handset acquisition. However, with a very
high mobile penetration rate in Australia, diabetes patients are likely to already be in
possession of mobile phones (Rao & Troshani, 2007a, 2007b). Nevertheless, DiaMonD
may require investment outlays from health providers. Initial setup, operational, and
supporting infrastructure costs may be barriers for its smooth adoption in Australia
(Khambati, Warren, Grundy, & Hosking, 2008).
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Sixth, legislation and perceptions of security and privacy are likely to have a strong
bearing on the successful adoption of DiaMonD in Australia. Although, the model
underpinning DiaMonD accounts for protection of patient information in terms of
privacy, security, and reliability, both individual and organisational adopters are
expected to require solid guarantees that continuous security improvements will reliably
safeguard the privacy of patient data. Nevertheless, extant research shows that these
concerns may dissipate overtime as mobile technology matures and benefits and
convenience begin to be experienced on a wide scale (Mirza et al., 2008).
Finally, other factors that, in various forms, may become barriers for the adoption of
DiaMonD in Australia include existing disparate legacy systems and possible
integration costs, lack of standards and limited bandwidth (Mirza et al., 2008).
Additionally, prioritisation and decision-making processes concerning the introduction
and diffusion of new health technologies in some areas in Australia are described to be
‘ad-hoc’ (Gallego, Fowler, & van Gool, 2008). Budgetary constrains often drive uptake
and diffusion of new technologies (Gallego et al., 2008).

6

Discussion

Modern healthcare delivery can benefit from the incorporation of various technology
enabled solutions. The preceding sections have served to describe and highlight the
example of DiaMonD – a pervasive wireless technology solution. We stress that we use
the name of the product not as a marketing ploy but rather to show that it is possible to
create superior technology enabled solutions that are simple and inexpensive. More
importantly, in many ways the strengths of this paper are not in the product or the
solution but rather its academic rigor. The vast majority of healthcare technology
solutions are developed and trailed by pharmaceutical companies and /or vendors. In
this instance we describe an independent research study. From the very onset where the
justification of patient self-empowerment was grounded in literature and the chronic
care model to the development of the revised systems development model for the
initiation and expansion of the physician-led pilot studies to the conceptualisation and
design of the delivery framework which ensures both tailoring to the local context and
yet a standard framework that thus support both between and within comparisons of
directional data and randomised control trials, to the defining of a suitable business
model to ensue that the solution is in fact sustainable to the role and incorporation of the
AMR methodology to enable continuous improvement and the power of the tools and
techniques of the knowledge economy to be accessed and utilised to ensure that the
solution provided to patients is at all times derived from the best set of inputs and the
latest knowledge. This in turn ensures that the principles of evidence based medicine are
adhered to, something that one cannot validate externally when trials and research are
being conducted by third parties such as vendors or pharmaceutical companies.
This paper then stands apart from the majority of healthcare IS/IT papers that describe a
technology solution to address a healthcare problem in that it develops an objective set
of criteria to measure success in a systematic fashion. Hence in the Australian context it
is essential that the delivery framework be defined to capture the key and unique
elements of the context as well as maintain the essential strengths of the solution. For
example under: 1) scope - it would be necessary to investigate in the long term the role
healthcare insurance companies would play; would they provide rebates or not for this
treatment and/or would this rebate be provide through Medicare, 2: Localize – it would
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be necessary to gather documents pertaining to current practices in Australia what is
considered appropriate blood readings and whether these differed from other standards;
3) Field – it is necessary to undergo relevant and appropriate ethical clearance in the
Australian context; 4) Evaluate – this would require several levels including comparing
and contrasting directional data and data from randomised control trials to those of
studies in other countries, across multiple studies within Australia and looking at
patients with different diabetic conditions as well as within the one study. In addition, it
would be essential to continuously update the inputs so as to preserve the AMR
methodology.
It is also important to note that the approach and elements described in this paper can be
used in other contexts in healthcare with other technologies. Thus, we believe another
contribution of this paper is to recommend that a suitable approach for applied research
initiatives in healthcare is to follow the essential steps we have outlined in this paper as
follows: 1) ground the role for the technology in a medical need that is identified in the
literature – e.g. in this study we have identified patient self-empowerment as identified
in the chronic care model, 2) look at existing established models and adapt them if
required rather than just move forward – ie the use of the refocused SDLC model, 3)
design a robust delivery framework that is flexible and yet robust to apply in various
contexts so as to facilitate between and within group comparisons of data, 4) design an
appropriate business model that ensures a sustained solution – for healthcare nothing is
worse than to offer patients a superior solution for only a short time – i.e. the use of the
web-based model, 5) incorporate the tools and techniques of the knowledge economy –
given the push to evidence-based medicine and the vast amount of data and information
in healthcare this is essential – i.e. the use of AMR methodology.

7

Future Developments

Given the general global consensus that effective and efficient healthcare delivery will
only occur through the judicious application of ICTs (FS, 2004; Kulkarni & Nathanson,
2005; Lacroix, 1999; Porter & Tiesberg, 2006; Wickramasinghe, 2007), it is inevitable
that, as we move into the second decade of the 21st century, the prevalence of ICTs to
facilitate the delivery of value driven healthcare will increase. We believe in such a
climate DiaMonD will be even more appropriate not only because it utilises ICTs to
provide superior healthcare delivery in the case of diabetic patients but it is also simple
to implement and use and cost effective both at the micro and macro levels. These levels
include both individual patients and clinicians and organisations including public and
private healthcare providers.
Nevertheless, it is anticipated that increased adoption and diffusion of chronic disease
mobile self-management solutions may depend increasingly less on technology and
increasingly more on acceptability by both patients and clinicians, on the one hand, and
on organisational healthcare providers, on the other. Clearly, mobile solutions such as
DiaMonD need to suit and be consistent with both patient lifestyles and work practices
undertaken by clinicians within healthcare provider organisations. This may be
indicative that education programs and promotional campaigns may need to be
undertaken for enhancing awareness and incentivising adoption. Tested processes and
procedures will result that greatly facilitate the creation of personal medical records and
effective and efficient forms of interaction with patients who suffer from a very
debilitating chronic disease such as diabetes.
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We also believe that the model underlying DiaMonD can be extended and adapted to
provide the necessary monitoring and self-management to other chronic diseases
including but not limited to hypertension, cardiac conditions and obesity. Diseases of
this nature require daily tests and continuous monitoring which are typically essential to
recommended treatment. However, widespread adoption and diffusion of mobile selfmanagement solutions for chronic disease management also implies that practical steps
may need to be undertaken in the future concerning the development, implementation,
and evaluation of information standards as well as subsequent integration with
healthcare legacy systems.
The effective application of wireless solutions such as DiaMonD entails the existence of
a trusting environment amongst all stakeholders including patients, physicians, insurers
and government. A trusting environment constitutes an important factor in the adoption
of DiaMonD and diabetes self-management service it provides. Trust determines the
patients’ expectations in their relationships with their healthcare providers, and it
increases their perceived certainty concerning the provider’s expected behaviour. More
generally, trust is essential in all economic activities where undesirable opportunistic
behaviour is likely to occur (Gefen, Karahanna, & Straub, 2003). However, trust
becomes particularly vital in a mobile environment in a healthcare setting, where
situational factors such as uncertainty or risk and information asymmetry are present
(Ba & Pavlou, 2002). On the one hand, patients maybe unable to judge the
trustworthiness of healthcare providers, and on the other, the latter can also easily take
advantage of the former by engaging in harmful opportunistic behaviours. For example,
healthcare providers can engage in illicit behaviours including selling or sharing the
personal information of its patients.
There are two key elements in any trusting environment including healthcare, namely,
security and privacy (Lu, Yu, Liu, & Yao, 2003). Security encompasses confidentiality,
authentication, and message integrity. Because DiaMonD can have limited computing
resources and wireless transmissions are more susceptible to hacker attacks, security
vulnerabilities can have serious consequences (Galanxhi-Janaqi & Nah, 2004; Lu et al.,
2003). These can be particularly serious in a healthcare setting. There are several
remedies against the dangers of insecurity. For example, public key infrastructure and
certification authorities which use public key cryptography to encrypt and decrypt
mobile transmissions and authenticate both patients and healthcare providers.
Ironically, the same information practices which provide value to both patients and
healthcare providers also cause privacy concerns. Some of these concerns include: the
type of information that can be collected about patients and the ways in which it will be
protected; the stakeholders and entities that can access this information and their
accountability; and the ways in which the information will be used (Galanxhi-Janaqi &
Nah, 2004). In healthcare settings where solutions such as DiaMonD are used, a trusting
environment can be encapsulated in perceived credibility (Lin & Wang, 2005; Wang,
Wang, Lin, & Tang, 2003). Evidence shows that there is a significant direct relationship
between perceived credibility and the intention to adopt general mobile services (Lin
and Wang, 2005, p. 410). However, we call for further research to test if this
relationship holds true in healthcare settings as well.
Finally, we are investigating the possibility of combining the wireless self-management
initiative with a community support perspective. Specifically, future research is
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currently being directed to investigate the manner in which social networks can be used
jointly with DiaMonD to facilitate healthcare delivery (S. Goldberg, 2009). Particularly,
we believe that this can be achieved through the development of diabetes patient’s own
social network (e.g. in Facebook). In this way, we will not only be empowering diabetes
patients to take control and responsibility for monitoring and managing their own care
(i.e. via DiaMonD) but also making available to them as conveniently and as
unobtrusively as possible access to the necessary community support via their social
networks. Preliminary trials offer encouraging findings (S. Goldberg, 2009). We firmly
believe that such a model has large and far reaching implications for delivery of care in
general as well as the economics of healthcare delivery and further research is current
underway.

8

Conclusions

We set out to present a case for the need to embrace a pervasive technology solution for
the superior monitoring of diabetes self-management for patients in Australia.
Developed by INET, we have argued that DiaMonD is a suitable wireless solution for
many reasons including that it is equally successful in controlling both type I and type II
diabetes, is as effective irrespective of patient’s age, socio economic standing or
location and has minimal risks and a very slight learning curve (if at all). We contend
that if such DiaMonD and its underlying model were to be incorporated into the
Australian context the growing segment of the population suffering from diabetes would
have a convenient, cost effective and superior means of monitoring and thereby
controlling their diabetes while in turn enjoying a better quality of life.
DiaMonD facilitates governments, associations, pharmaceutical firms, researchers,
healthcare professionals and other healthcare stakeholders that are looking for improved
and measurable outcomes among patients suffering from diabetes. Specific benefits
range from decreasing diabetes related complications to reducing the economic burden
on the health system. We realise that further research is required to test DiaMonD in the
Australian healthcare setting including testing of aspects, such as perceived ease of use,
perceived usefulness, etc. Nevertheless, we conclude by warning that if a pervasive
technology solution is not sought for the monitoring and support of diabetes selfmanagement not only will this chronic disease become a silent epidemic but it will also
be a very costly burden for both the healthcare sector and the community at large.
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